Literature DB >> 2319391

The ultrastructure of plexogenic pulmonary arteriopathy.

P Smith1, D Heath, M Yacoub, B Madden, A Caslin, J Gosney.   

Abstract

The lungs from 16 cases of plexogenic pulmonary arteriopathy obtained at heart-lung transplantation, half of which had primary pulmonary hypertension, were examined by electron microscopy. From these the probable pathogenesis of pulmonary arterial intimal fibrosis in plexogenic pulmonary arteriopathy was deduced. The earliest detectable change was migration of smooth muscle cells from the media, through the internal elastic lamina into the intima. These cells collected beneath the endothelium and lost many of their myofilaments to become myofibroblasts. They were associated with ground substance but scanty collagen fibrils. As the quantity of interstitial collagen increased, the myofibroblasts reverted to a muscular structure, became elongated, and assumed a regular, circumferential orientation. This later stage coincided with the development of plexiform lesions. At both early and later stages, the muscular pulmonary arteries were contracted but not markedly so, and muscular evaginations were not seen. On the other hand, the cellular intimal proliferations developed early and were occlusive. This suggests that occlusion of small pulmonary arterial vessels by myofibroblasts may be at least as important as vasoconstriction in the early elevation of the pulmonary vascular resistance in primary pulmonary hypertension.

Entities:  

Mesh:

Year:  1990        PMID: 2319391     DOI: 10.1002/path.1711600204

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

Review 1.  New insights into the pathogenesis and treatment of primary pulmonary hypertension.

Authors:  N Rudarakanchana; R C Trembath; N W Morrell
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

2.  Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline.

Authors:  Hong-Liang Zhang; Zhi-Hong Liu; Qin Luo; Yong Wang; Zhi-Hui Zhao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  CHANGES IN PULMONARY VASCULATURE IN LUNG DISEASES WHICH LEAD TO PULMONARY HYPERTENSION.

Authors:  R B Batra; S K Basu
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Ultrastructure of the lung in chronic hypoxia.

Authors:  P Smith
Journal:  Thorax       Date:  1994       Impact factor: 9.139

5.  Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.

Authors: 
Journal:  Thorax       Date:  1994       Impact factor: 9.139

6.  The amiloride derivative phenamil attenuates pulmonary vascular remodeling by activating NFAT and the bone morphogenetic protein signaling pathway.

Authors:  Mun Chun Chan; Alexandra S Weisman; Hara Kang; Peter H Nguyen; Tyler Hickman; Samantha V Mecker; Nicholas S Hill; Giorgio Lagna; Akiko Hata
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

Review 7.  Caveolins and lung function.

Authors:  Nikolaos A Maniatis; Olga Chernaya; Vasily Shinin; Richard D Minshall
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

8.  Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression.

Authors:  Mun Chun Chan; Aaron C Hilyard; Connie Wu; Brandi N Davis; Nicholas S Hill; Ashish Lal; Judy Lieberman; Giorgio Lagna; Akiko Hata
Journal:  EMBO J       Date:  2009-12-17       Impact factor: 11.598

9.  Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.

Authors:  K M Mair; M R MacLean; I Morecroft; Y Dempsie; T M Palmer
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

Review 10.  Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension.

Authors:  Pravin B Sehgal; Somshuvra Mukhopadhyay
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-15       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.